Cite
HARVARD Citation
Lebek, S. et al. (2020). Angiotensin‐converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin‐converting enzyme 2 in patients with cardiovascular disease. European journal of heart failure. pp. 2248-2257. [Online].